Serum ADA and other laboratory parameters were measured at diagnosis.<h4>Results</h4>Precursor cell lymphomas showed higher rates of bone marrow involvement, peripheral blood involvement, and clinical stage IV disease compared to mature cell lymphomas. This evidence concerns the gene ADA and lymphoma.